Skip to Main Content

Author Details

Karolina Edlund
Leibniz Research Centre for Working Environment and Human Factors at TU Dortmund
2008
81
34
Emma Lundberg (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37939855Inhibition of the renal apical sodium dependent bile acid transporter prevents cholemic nephropathy in mice with obstructive cholestasis.J Hepatol2024
36670508Inhibiting the glycerophosphodiesterase EDI3 in ER-HER2+ breast cancer cells resistant to HER2-targeted therapy reduces viability and tumour growth.J Exp Clin Cancer Res2023
38053838Increased sinusoidal export of drug glucuronides is a compensative mechanism in liver cirrhosis of mice.Front Pharmacol2023
37690743Risk assessment of parabens in a transcriptomics-based in vitro test.Chem Biol Interact2023
37280200Colitis ameliorates cholestatic liver disease via suppression of bile acid synthesis.Nat Commun2023
37073116Long-term hypercaloric diet exacerbates metabolic liver disease in PNPLA3 I148M animals.Liver Int2023
34717914The hepatocyte export carrier inhibition assay improves the separation of hepatotoxic from non-hepatotoxic compounds.Chem Biol Interact2022
35416653Classification of Developmental Toxicants in a Human iPSC Transcriptomics-Based Test.Chem Res Toxicol2022
35963427In vitro/in silico prediction of drug induced steatosis in relation to oral doses and blood concentrations by the Nile Red assay.Toxicol Lett2022
36359802High Accuracy Classification of Developmental Toxicants by In Vitro Tests of Human Neuroepithelial and Cardiomyoblast Differentiation.Cells2022
35863491Identification of an FXR-modulated liver-intestine hybrid state in iPSC-derived hepatocyte-like cells.J Hepatol2022
35099568Correction to: Toxicogenomics directory of chemically exposed human hepatocytes.Arch Toxicol2022
34558834Transcriptomic Cross-Species Analysis of Chronic Liver Disease Reveals Consistent Regulation Between Humans and Mice.Hepatol Commun2022
34095968Contribution to the ongoing discussion on fluoride toxicity.Arch Toxicol2021
33542080Gene Expression-Based Prediction of Neoadjuvant Chemotherapy Response in Early Breast Cancer: Results of the Prospective Multicenter EXPRESSION Trial.Clin Cancer Res2021
34433051Epigenomic and transcriptional profiling identifies impaired glyoxylate detoxification in NAFLD as a risk factor for hyperoxaluria.Cell Rep2021
34685496Spatio-Temporal Multiscale Analysis of Western Diet-Fed Mice Reveals a Translationally Relevant Sequence of Events during NAFLD Progression.Cells2021
34298839Prognostic Impact of Immunoglobulin Kappa C (<i>IGKC</i>) in Early Breast Cancer.Cancers (Basel)2021
32382957Toxicity of fluoride: critical evaluation of evidence for human developmental neurotoxicity in epidemiological studies, animal experiments and in vitro analyses.Arch Toxicol2020
31919559Inflammation-associated suppression of metabolic gene networks in acute and chronic liver disease.Arch Toxicol2020
33003293Prognostic Significance of Interferon-γ and Its Signaling Pathway in Early Breast Cancer Depends on the Molecular Subtypes.Int J Mol Sci2020
30639618Prognostic Impact of Tumor Cell Programmed Death Ligand 1 Expression and Immune Cell Infiltration in NSCLC.J Thorac Oncol2019
31250071Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations.Arch Toxicol2019
31130451Road Map for Development of Stem Cell-Based Alternative Test Methods.Trends Mol Med2019
30678289HR-MAS NMR Based Quantitative Metabolomics in Breast Cancer.Metabolites2019
30653260LIPG-promoted lipid storage mediates adaptation to oxidative stress in breast cancer.Int J Cancer2019
29206323Impact of intratumoral heterogeneity of breast cancer tissue on quantitative metabolomics using high-resolution magic angle spinning <sup>1</sup> H NMR spectroscopy.NMR Biomed2018
30317417Relevance of the incubation period in cytotoxicity testing with primary human hepatocytes.Arch Toxicol2018
30511339Toxicogenomics directory of rat hepatotoxicants in vivo and in cultivated hepatocytes.Arch Toxicol2018
27896396Metabolic profiling of ob/ob mouse fatty liver using HR-MAS <sup>1</sup>H-NMR combined with gene expression analysis reveals alterations in betaine metabolism and the transsulfuration pathway.Anal Bioanal Chem2017
28281552Reaching the limits of prognostication in non-small cell lung cancer: an optimized biomarker panel fails to outperform clinical parameters.Mod Pathol2017
28251349Prognostic significance of interferon regulating factor 4 (IRF4) in node-negative breast cancer.J Cancer Res Clin Oncol2017
29118048RANK rewires energy homeostasis in lung cancer cells and drives primary lung cancer.Genes Dev2017
29112949Integrative analysis of genome-wide gene copy number changes and gene expression in non-small cell lung cancer.PLoS One2017
28652252Glycerol-3-phosphate Acyltransferase 1 Promotes Tumor Cell Migration and Poor Survival in Ovarian Carcinoma.Cancer Res2017
28585074Subtype-specific prognostic impact of different immune signatures in node-negative breast cancer.Breast Cancer Res Treat2017
26701726The protein kinase LKB1 negatively regulates bone morphogenetic protein receptor signaling.Oncotarget2016
28743474Corrigendum to "Gene networks and transcription factor motifs defining the differentiation of human stem cells into hepatocyte-like cells" [J Hepatol 2015;63:934-942].J Hepatol2016
27699219Profiling cancer testis antigens in non-small-cell lung cancer.JCI Insight2016
27926932Epsin Family Member 3 and Ribosome-Related Genes Are Associated with Late Metastasis in Estrogen Receptor-Positive Breast Cancer and Long-Term Survival in Non-Small Cell Lung Cancer Using a Genome-Wide Identification and Validation Strategy.PLoS One2016
27495736Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancer.BMC Cancer2016
27339419Gene network activity in cultivated primary hepatocytes is highly similar to diseased mammalian liver tissue.Arch Toxicol2016
24789573The human gastrointestinal tract-specific transcriptome and proteome as defined by RNA sequencing and antibody-based profiling.J Gastroenterol2015
26488136The Human Endometrium-Specific Proteome Defined by Transcriptomics and Antibody-Based Profiling.OMICS2015
26408687Gelsolin Is Associated with Longer Metastasis-free Survival and Reduced Cell Migration in Estrogen Receptor-positive Breast Cancer.Anticancer Res2015
26608184Identification of sample annotation errors in gene expression datasets.Arch Toxicol2015
25884297Microsatellite instability and mutations in BRAF and KRAS are significant predictors of disseminated disease in colon cancer.BMC Cancer2015
26022688Gene networks and transcription factor motifs defining the differentiation of stem cells into hepatocyte-like cells.J Hepatol2015
25813475LRIG1 is a prognostic biomarker in non-small cell lung cancer.Acta Oncol2015
25449785Prognostic impact of COX-2 in non-small cell lung cancer: a comprehensive compartment-specific evaluation of tumor and stromal cell expression.Cancer Lett2015
  • 1 - 50 of 81

Recommended Authors

Darragh G McArt
Queen's University Belfast
Career Start Year 2009
Number of shared co-authors 0
Kris Ylaya
Center for Cancer Research, National Cancer Institute
Career Start Year 2008
Number of shared co-authors 0
Gabriele Zoppoli
University of Genoa and Ospedale Policlinico San Martino
Career Start Year 2008
Number of shared co-authors 0
Yang Xie
Quantitative Biomedical Research Center
Career Start Year 2007
Number of shared co-authors 1
Esther Herpel
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 1
Albrecht Stenzinger
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 1
Tuan Zea Tan
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 0
Benjamin Haibe-Kains
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2004
Number of shared co-authors 0
Andrew V Kossenkov
The Wistar Institute
Career Start Year 2003
Number of shared co-authors 0
Lixia Diao
The University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 0
Leslie Cope
Johns Hopkins University School of Medicine
Career Start Year 2003
Number of shared co-authors 0
Frederick Klauschen
Institute of Pathology, Ludwig-Maximilians-Universitat Munchen
Career Start Year 2002
Number of shared co-authors 1
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 0
Syed Haider
Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 1
Michael Slifker
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 0
Darran P O'Connor
UCD Conway Institute, University College Dublin
Career Start Year 2001
Number of shared co-authors 10
Loris De Cecco
Fondazione IRCCS Istituto Nazionale dei Tumori
Career Start Year 2000
Number of shared co-authors 0
Lodewyk F A Wessels
University Medical Centre Mannheim, University of Heidelberg
Career Start Year 2000
Number of shared co-authors 2
Benedikt Brors
German Cancer Research Center (DKFZ)
Career Start Year 1997
Number of shared co-authors 1
William M Gallagher
All-Island Cancer Research Institute, UCD Conway Institute, University College Dublin
Career Start Year 1996
Number of shared co-authors 20
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1996
Number of shared co-authors 1
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 0
Sudhir Varma
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 1
Holger S??ltmann
German Cancer Research Center (DKFZ)
Career Start Year 1993
Number of shared co-authors 1
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year 1992
Number of shared co-authors 2
Keith A Baggerly
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 0
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 0
John W M Martens
Erasmus Medical Center (MC) Cancer Institute
Career Start Year 1989
Number of shared co-authors 1
Stephen M Hewitt
Center for Cancer Research, National Cancer Institute
Career Start Year 1988
Number of shared co-authors 2
Paul C Boutros
University of California los angeles
Career Start Year 1970
Number of shared co-authors 2

Collaborators

J??rg Rahnenf??hrer
TU Dortmund University
Co-authored papers 38
Patrick Micke
Uppsala University
Co-authored papers 33
Fredrik Pont??n
Uppsala University
Co-authored papers 20
Agapios Sachinidis
Institute of Neurophysiology, University of Cologne
Co-authored papers 13
Mathias Uhl??n
KTH Royal Institute of Technology
Co-authored papers 11
Bj??rn M Hallstr??m
Division of Clinical Genetics, Lund University
Co-authored papers 11
Linn Fagerberg
KTH Royal Institute of Technology
Co-authored papers 11
Johanna S M Mattsson
Uppsala University
Co-authored papers 10
Cecilia Lindskog
Uppsala University
Co-authored papers 8
Karin Jirstr??m
Lund University
Co-authored papers 8
Adil Mardinoglu
Royal Institute of Technology Science for Life Laboratory Stockholm Sweden.
Co-authored papers 7
Caroline Kampf
Uppsala University
Co-authored papers 6
Michael Bergqvist
Umea University
Co-authored papers 6
Dijana Djureinovic
Yale University School of Medicine
Co-authored papers 5
Annette Hasenburg
University Medical Center, Johannes Gutenberg University Mainz
Co-authored papers 5
Anna Asplund
Uppsala University
Co-authored papers 5
Hans Brunnstr??m
Lund University
Co-authored papers 4
Evelina Sj??stedt
Karolinska Institutet
Co-authored papers 4
Jens Nielsen
Chalmers University of Technology
Co-authored papers 4
Helgi Birgisson
The Icelandic Cancer Registry
Co-authored papers 3
Bengt Glimelius
Uppsala University
Co-authored papers 3
Emma Lundberg (CM4AI)
Stanford University
Co-authored papers 3
Tobias Sj??blom
Uppsala University
Co-authored papers 3
Jacob Odeberg
The Arctic University of Norway
Co-authored papers 3
Angelika Danielsson
Uppsala University
Co-authored papers 3
Peter Nilsson
Linkoping University
Co-authored papers 3
??sa Sivertsson
KTH-Royal Institute of Technology
Co-authored papers 3
Jenny Ottosson
Bio Pharmaceuticals R&D
Co-authored papers 2
Jörn Walter
Co-authored papers 2
Kalle von Feilitzen
KTH Royal Institute of Technology
Co-authored papers 2
Release 1.2